menu search

Heartflow, longview acquisition spac deal called off

HeartFlow Holding Inc and a special purpose acquisition company, Longview Acquisition Corp II (NYSE: LGV), have called off merger plans that woul...

February 7, 2022, 6:00 am

Will irhythm technologies stock continue to see higher levels after a 20% rally in a month?

The stock price of iRhythm Technologies, a healthcare company that provides ambulatory electrocardiogram and c...

January 24, 2022, 7:00 am

Will irhythm technologies stock continue to see higher levels after a 20% rally in a month?

The stock price of iRhythm Technologies, a healthcare company that provides ambulatory electrocardiogram and c...

January 24, 2022, 7:00 am

Will irhythm technologies stock continue to see higher levels after a 20% rally in a month?

The stock price of iRhythm Technologies, a healthcare company that provides ambulatory electrocardiogram and c...

January 24, 2022, 7:00 am

Abiomed (abmd) reports positive data backing precardia system

Abiomed's (ABMD) preCARDIA system has proven to be effective in reducing cardiac filling pressures and ...

January 19, 2022, 1:05 pm

Abiomed (abmd) reports positive data backing precardia system

Abiomed's (ABMD) preCARDIA system has proven to be effective in reducing cardiac filling pressures and ...

January 19, 2022, 1:05 pm

Abiomed (abmd) reports positive data backing precardia system

Abiomed's (ABMD) preCARDIA system has proven to be effective in reducing cardiac filling pressures and ...

January 19, 2022, 1:05 pm

Angion (angn) kidney drug misses third study goal in 2021

Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fa...

December 13, 2021, 1:50 pm

Angion (angn) kidney drug misses third study goal in 2021

Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fa...

December 13, 2021, 1:50 pm

Angion (angn) kidney drug misses third study goal in 2021

Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fa...

December 13, 2021, 1:50 pm

Zynex to display its cm-1500 fluid monitoring system at the american society of anesthesiologists annual conference

ENGLEWOOD, Colo., Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture a...

October 8, 2021, 9:15 am

Zynex to display its cm-1500 fluid monitoring system at the american society of anesthesiologists annual conference

ENGLEWOOD, Colo., Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture a...

October 8, 2021, 9:15 am

Zynex to display its cm-1500 fluid monitoring system at the american society of anesthesiologists annual conference

ENGLEWOOD, Colo., Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture a...

October 8, 2021, 9:15 am

Biotricity launches biocare cardiac application for samsung's galaxy watch4 series

REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ: BTCY), a medical diagnostic and consumer healthcare technology company, to...

October 8, 2021, 8:16 am

Biotricity launches biocare cardiac application for samsung's galaxy watch4 series

REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ: BTCY), a medical diagnostic and consumer healthcare technology company, to...

October 8, 2021, 8:16 am

Biotricity launches biocare cardiac application for samsung's galaxy watch4 series

REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ: BTCY), a medical diagnostic and consumer healthcare technology company, to...

October 8, 2021, 8:16 am

Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference

MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...

October 7, 2021, 3:11 pm

Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference

MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...

October 7, 2021, 3:11 pm

Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference

MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ --  CytoSorbents Corporation  (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...

October 7, 2021, 3:11 pm


Search within

Pages Search Results: